Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Document › Details

Mologen AG. (7/17/18). "Press Release: Resolved Reverse Share Split Implemented [NOT FOR UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH UNLAWFUL]".

Organisations Organisation Mologen AG
  Group Mologen (Group)
  Organisation 2 Frankfurt Stock Exchange (FSE)
  Group Deutsche Börse (Group)
Products Product investment banking
  Product 2 lefitolimod (MGN1703)
Person Person Nickolaus, Claudia (Mologen 201407– Head Investor Relations)
     


   
Record changed: 2018-08-04

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

More documents for Mologen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top